Figure 4.

In vivo anticancer evaluation of Cu@cLAs. (a) Schematic illustration of MCF-7/R tumor xenograft construction, medication, and survival cycle. (b) Photos showing the tumor size in mice during different treatments. (c) Tumor volume change during therapy. (d) Digital pictures of tumors from the MCF-7/R tumor-bearing mice after 21 days of therapy and tumor inhibition rate of each therapeutic group after treatment. (e) Percent survival of mice after different treatments. (f) Body weight changes of the mice during therapy. (g) H&E staining and TUNEL staining of tumor sections from the MCF-/7R tumor-bearing mice.